Literature DB >> 34877545

Global metabolome profiling of COVID-19 respiratory specimen using high-resolution mass spectrometry (HRMS).

Nupur Sharma1, Sadam H Bhat1, Gaurav Tripathi1, Manisha Yadav1, Babu Mathew1, Vasundhra Bindal1, Shvetank Sharma1, Ekta Gupta2, Jaswinder Singh Maras1, Shiv Kumar Sarin3.   

Abstract

Here we describe a protocol for identifying metabolites in respiratory specimens of patients that are SARS-CoV-2 positive, SARS-CoV-2 negative, or H1N1 positive. This protocol provides step-by-step instructions on sample collection from patients, followed by metabolite extraction. We use ultra-high-pressure liquid chromatography (UHPLC) coupled with high-resolution mass spectrometry (HRMS) for data acquisition and describe the steps for data analysis. The protocol was standardized with specific customization for SARS-CoV-2-containing respiratory specimens. For complete details on the use and execution of this protocol, please refer to Maras et al. (2021).
© 2021 The Author(s).

Entities:  

Keywords:  Clinical Protocol; Health Sciences; Immunology; Mass Spectrometry; Metabolomics

Mesh:

Year:  2021        PMID: 34877545      PMCID: PMC8639449          DOI: 10.1016/j.xpro.2021.101051

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

This protocol has been used by our group (Maras et al., 2018, 2020, 2021; Bhat et al., 2020), and other groups (Weiss et al., 2016; Moreau et al., 2020) and (Castelli et al., 2021) for metabolome analysis. Respiratory specimens were collected under the guidelines provided by the Centers for Disease Control and Prevention (Control and Prevention, 2020). The Viral Transport Media utilized is made of Hanks Balanced Salt Solution and contains a protective protein, antibiotics to control microbial and fungal contamination, and buffers to control the pH. Phenol red is used as a pH indicator. The medium also contains a cryoprotectant which helps in preserving the viruses if specimens are frozen for prolonged storage.

Nasopharyngeal specimen (NP) collection

Tilt the head of the patient 70° to the back. Gently insert and roll the swab with a flexible shaft (wire or plastic) through the nostril parallel to the palate (not upwards) until resistance is encountered or the distance is equivalent to that from the ear to the nostril of the patient, indicating contact with the nasopharynx. Leave the swab in place for a few seconds to absorb secretions. Slowly remove the swab while rotating it. Place swab, tip first, into the viral transport media containing tube provided. Specimens can be collected from both sides using the same swab, but it is not necessary to collect specimens from both sides if the swab is saturated with fluid from the first collection.

Oropharyngeal (OP) (throat) specimen collection

Insert swab into the posterior pharynx and tonsillar areas. Rub swab over both tonsillar pillars and posterior oropharynx and avoid touching the tongue, teeth, and gums. Place swab, tip first, into the viral transport media to make the respiratory specimen. Mix the NP and the OP specimen to form a respiratory specimen which can be used for RT-PCR based detection of viral presence and also could be used as a starting material for multi-omics analysis. The mixing of NP or OP is not mandatory and can be analyzed individually. An aliquot of the respiratory specimens was sent for SARS-CoV-2 detection, and the other was utilized for metabolomics analysis. Further, respiratory specimens can be stored in −80°C for a year. For better results, it should be used within 2 months for analysis

Key resources table

Materials and equipment

Internal standards for untargeted analysis External standard for untargeted analysis Solvent A for untargeted analysis Always prepare fresh Solvent A. To prevent contamination of any particulate matter filter the solvent with 0.45 μm filter. Then place the bottle in an ultrasonic bath for 10 min to degas the solvent. To avoid shift in the retention time, the same sample set should be run within 2–3 days with the fresh mobile phase solvent. CRITICAL: Formic acid is highly caustic and flammable liquid, with a strong pungent odor. It can cause damage to skin, eyes, and mucosal surfaces. If contact occurs, the person should flush the affected areas immediately with plenty of water, followed by washing with soap and water. Wear protective gloves, laboratory coat, eye and face protection while working with this chemical Solvent B for untargeted analysis Always prepare fresh Solvent B. To prevent contamination of any particulate matter filter the solvent with 0.45 μm filter. Mix the solvent gently. Then place the bottle in an ultrasonic bath for 10 min to degas the solvent. To avoid shift in the retention time, the same sample set should be run within 2–3 days with the fresh mobile phase solvent. CRITICAL: Acetonitrile is a colorless volatile liquid with an aromatic odor, highly flammable and hazardous if inhaled or absorbed by skin. One should use a fume hood to minimize exposure to this substance. Wear protective clothing to avoid skin or eye contact, inhalation or ingestion. A long-sleeved laboratory coat or gown, rubber gloves, safety goggles and a face mask as a minimum standard. LC-MS setup for untargeted analysis: Metabolomic analysis is performed on the Thermo ScientificTM UHPLC system combined with Q Exactive Orbitrap Mass Spectrometers. Samples are analyzed in single runs for positive and negative modes using the parameters shown in Table 1.
Table 1

LC-MS parameter settings

IonizationElectrospray ionization
MS1 and MS2 mass rangesm/z 150–m/z 2,000
Sheath gas flow rate54
Auxiliary gas flow rate13
Resolution70,000 m/Δ m
Collision gasNitrogen
Collision energy (positive mode/negative mode)+40/-42 eV
Collision energy spread15 eV
Ion source gas 1 (air; positive mode/negative mode)40/50 psi
Ion source gas 2 (air; positive mode/negative mode)80/50 psi
Curtain gas (nitrogen)30 psi
Ion source temperature (positive mode/negative mode)250°C/300°C
Ion spray voltage floating (positive mode/negative mode)5500–4500 V
Declustering potential (positive mode /negative mode)80/−80 eV
LC-MS parameter settings Hypersil GOLD™ C18 Selectivity HPLC Column is used as a stationary phase to separate respiratory metabolites. Column Specifications are mentioned in Table 2.
Table 2

Column formats

Column formatAnalytical column
For Use WithLC/MS
Max. Pressure5800 psi (400 bar)
pH1 to 11
Surface Area220 m2/g
USP TypeL1
Product LineHypersil GOLD
Carbon Load11%
EndcappedYes
Diameter (Metric)2.1 mm
Length (Metric)100 mm
Particle Size3 μm
Pore Size175 Å
Temperature60°C
Stationary PhaseC18 Selectivity
Packing MaterialSpherical, Fully Porous, Ultrapure Silica
Column TypeReversed Phase
Column formats The mobile phases consist of (A) Acetonitrile with 1% formic acid and (B) Milli-Q-water with 0.1% formic acid, used for gradient elution (Table 3).
Table 3

LC-MS gradient for untargeted metabolomics

S. No.Time (min)Flow (mL/min)% BCurve
100.5005.05
210.5005.05
3170.50099.05
4210.50099.05
5220.5005.05
625Stop Run
LC-MS gradient for untargeted metabolomics Overall run cycle time per sample is 25 min.

Step-by-step method details

An outline of the procedures is described in Figure 1. A total of 500 μL respiratory specimens was heat-inactivated using heat block at 95°C for 15 min in a BSL3 lab. Heat inactivated respiratory specimens were subjected to homogenization by probe sonicator (steps 1–6). Respiratory metabolites were extracted by organic phase extraction method (steps 7–18) for untargeted metabolomics using LCMS (steps 19–20). The obtained data are analyzed using the Compound discoverer version 3.1 (steps 21–31).
Figure 1

Showing an outline of the respiratory specimen collection, preparation, and data analysis

Showing an outline of the respiratory specimen collection, preparation, and data analysis

Heat inactivation of virus

Timing: 15 min/sample This step is crucial to inactivate the virus as a safety measure to mitigate the risk of infection during sample preparation. The collected respiratory specimens are placed on a heating block at 95°C for 15 min (Batejat et al., 2021) to inactivate the virus. Pause point: Respiratory specimen can be stored in −80°C upto 4 weeks

Homogenization of respiratory specimen

Timing: 5–7 min/sample Respiratory specimens may contain host cells, mucus, bacterial and viral components. Thus, it is essential to homogenize the samples. CRITICAL: The high frequency sound emitted by the sonicator can damage hearing. Therefore place the sample in a noise isolating chamber and always close the door while operating. Do not grasp an activated horn or touch the tip of a vibrating probe. It can cause severe burns and tissue damage. Take 100 μL of respiratory specimen in a new microcentrifuge tube (MCT) and keep it on ice during homogenization. Place the sample in a noise isolating chamber and submerge the sonicator probe into the sample. The probe should not touch the walls of MCT as it will break the tube and destroy the sample. Close the door of the chamber after correctly placing the sample tube. Run the program at Power 20%, Run time 5 min (Cycle - 10 s ON, 10 s OFF) and temperature 22°C. Remove and clean the probe with ethanol. Keep the sample on ice during all the homogenization steps step 2–6. Pause point: Respiratory specimen can be stored in −80°C upto 4 weeks

Organic phase metabolite extraction

Timing: ∼15 h/sample To reduce the complexity of the sample, proteins must be removed. Hence, organic phase extraction will remove the proteins through precipitation and dissolve the metabolites in solution. Add 100 uL of homogenized respiratory specimen to 400 uL of 100% chilled methanol. Vortex it for 10 s. Keep it in −20°C for 10–12 h. Centrifuge the sample at 18,000g for 10 min. Take the supernatant into a new tube and discard the pellet. Freeze-dry the sample completely using a vacuum concentrator. Dissolve the sample in 105 uL of solvent (5% ACN (Acetonitrile), 5% Internal Standard, 95% water). Vortex the sample for 10 s. Pipette 80 uL of sample solution into HPLC tube. Add the remaining 25 μL in a different tube to prepare a pooled quality control sample (In this tube all the samples prepared for run are pooled together). QC samples are required to correct the small levels of variation within samples from the same group, to quantitatively measure technical reproducibility and to integrate data from different analytical experiments. The peak features exceeding 30% coefficient of variation (CV) values and less than 0.7 r2 for Coefficient of correlation in QC samples are excluded. Make a dilution of the Pool solution. Make a blank with 100% ACN.

Sample run and analysis

Timing: 30–40 min/sample This step provides you MS.raw file for each sample for further analysis. Lay down the sample sequence as exemplified in Figure 2.
Figure 2

Showing an exemplary sample sequence list

Showing an exemplary sample sequence list Set the run with LC-MS parameters described in Table 1 (Boudah et al., 2014) and run gradient is described in Table 3. Further details are provided in Table S1.

Peak picking and software analysis

Timing: 6–8 h/sample MS.raw file is mapped on different metabolome databases for metabolite annotation that is exported in excel sheet for statistical analysis in order to interpret the data. Standard determination at both positive and negative mode as shown in Figure 3.
Figure 3

Showing mass spectral peak of standard metabolites

Showing mass spectral peak of standard metabolites Data analysis using Compound discoverer ver. 3.1: Compound Discoverer is a unique small molecule structure recognition software. It uses accurate mass data, isotope pattern matching, fragment matching, and mass spectral library search to identify the structure of small molecules. It is a qualitative data processing application that can process accurate mass spectra of the entire Thermo Scientific high-resolution mass spectrometer product line. Compound Discoverer provides a set of processing tools called Nodes, which can be combined into a processing workflow in many different ways according to the type of experiment you perform and the questions you must answer. These workflows can be saved and reused as templates. Additionally, users can even design and write their own nodes for use in Compound Discoverer. Open the Compound discoverer ver. 3.1 application. Click ‘‘New Study and Analysis” (in red borders; Figure 4).
Figure 4

Graphical representation of step 22

Compound discoverer 3.1 start page for new study and analysis.

Graphical representation of step 22 Compound discoverer 3.1 start page for new study and analysis. The New Study and Analysis Wizard opens. Click “Next” (indicated by the red arrow in Figure 5).
Figure 5

Graphical representation of step 23

Showing New Study and Analysis Wizard.

Graphical representation of step 23 Showing New Study and Analysis Wizard. Define the study type, name of study and storage location (underlined in red). Study template file and workflow can also be optionally selected. Then click “Next” (red arrow; Figure 6).
Figure 6

Graphical representation of step 24

Name the study and describe the path of study.

Graphical representation of step 24 Name the study and describe the path of study. Click “Add Files” on the Input File Selection page of the wizard to select the sample data files. The file names of the selected files appear in the Files box. And then click “Next” (indicated by the red arrow in Figure 7).
Figure 7

Graphical representation of step 25, showing Input File Selection Dialogue Box

Graphical representation of step 25, showing Input File Selection Dialogue Box In the Input File Characterization dialog box, define the Sample Type for blanks, samples, and pools and click on “Finish” (Figure 8).
Figure 8

Graphical representation of step 26

In the Input File Characterization dialog box define the sample type.

Graphical representation of step 26 In the Input File Characterization dialog box define the sample type. Select the metabolomics workflow in the Workflows tab appear in the set of tabbed pages. The workflow is utilized by Maras et al. (2021) shown below in Figure 9: each node is explained in user manual provided at https://assets.thermofisher.com › CMD › manuals
Figure 9

Graphical representation of step 27, showing untargeted metabolome workflow

Name the result file in the Analysis pane and click Run to submit the analysis to the job queue (Figure 10).
Figure 10

Graphical representation of step 28, name the result file and click ‘Run’

Graphical representation of step 27, showing untargeted metabolome workflow Graphical representation of step 28, name the result file and click ‘Run’ When the job is done, a result layout file will appear (Figure 11), export the result file in “.xlsx” format.
Figure 11

Showing result layout file (step 29)

Showing result layout file (step 29) Peak picking based on “mass + retention time, mass + retention time + spectral match and mass alone.” In the excel file obtained, remove the duplicates (red borders) based on average area intensity of the samples (Figure 12).
Figure 12

Showing excel sheet composed of metabolite name, formula, molecular weight, area(max), retention time, sample wise area intensity, etc

Showing excel sheet composed of metabolite name, formula, molecular weight, area(max), retention time, sample wise area intensity, etc Create a comma delimited file of annotated metabolites along with their sample wise area intensity and do statistical analysis using software such as Metaboanalyst webserver (Chong et al., 2019) (Figure 13).
Figure 13

Showing expected outcomes: of VTM metabolome

(A) Volcano plot differentially regulated metabolites in COVID-19 +ve compared to COVID-19 −ve samples (p < 0.05, FC > 1.5).

(B) Pathway and metabolite set enrichment analysis (KEGG) for the upregulated and downregulated metabolites (FC > 1.5, p < 0.05) in COVID19-positive respiratory specimen.

(C) Mean decrease in accuracy of the metabolites (Red = upregulated and Green = downregulated and yellow = unchanged) in COVID-19 +ve as compared to COVID-19 −ve. Also, AUROC analysis of N-acetylserotonin (C00978) and azelaic acid (C08261) with AUC = 0.987 CI (0.98–1) p < 0.05 along with prediction class probability score plot showing segregation of COVID-19 positive and negative.

Showing expected outcomes: of VTM metabolome (A) Volcano plot differentially regulated metabolites in COVID-19 +ve compared to COVID-19 −ve samples (p < 0.05, FC > 1.5). (B) Pathway and metabolite set enrichment analysis (KEGG) for the upregulated and downregulated metabolites (FC > 1.5, p < 0.05) in COVID19-positive respiratory specimen. (C) Mean decrease in accuracy of the metabolites (Red = upregulated and Green = downregulated and yellow = unchanged) in COVID-19 +ve as compared to COVID-19 −ve. Also, AUROC analysis of N-acetylserotonin (C00978) and azelaic acid (C08261) with AUC = 0.987 CI (0.98–1) p < 0.05 along with prediction class probability score plot showing segregation of COVID-19 positive and negative.

Expected outcomes

Untargeted metabolomics analysis of the respiratory specimen could yield close to 20 thousand to 40 thousand ions depending on the machine sensitivity and specificity. Those ions which qualify analytical quality determination are subjected to annotation using Spectral Database and database of pure compound which document RT and intact mass for the same in the compound discoverer software. The compound discoverer software returns annotation for the probable ions which need to be checked individually and processed for statistical analysis for the study group. Statistical analysis of the metabolites within the VTM showed 106 metabolites that were significantly dysregulated in COVID-19 positive patients. Metabolites like N-acetylserotonin (C00978) and azelaic acid (C08261) had the highest mean decrease in accuracy and showed a combined diagnostic efficiency of 0.987 (0.98–1) for SARS-CoV-2 positive segregation from negatives. Pathway analysis revealed significant increase in pathways linked to biosynthesis of unsaturated fatty acids, glycerophospholipid metabolism, ubiquinone/terpenoid-quinone biosynthesis, aminoacyl-tRNA biosynthesis and amino acid metabolism including phenylalanine, tyrosine and tryptophan biosynthesis whereas, pathways linked to thiamine metabolism, one carbon pool by folate, vitamin B6 metabolism, riboflavin metabolism and steroid biosynthesis were decreased (Figure 13). Therefore, SARS-CoV-2 infection tends to change the metabolic phenotype of respiratory specimens.

Limitations

The precise determination of the actual quantitate of the metabolites could not be determined by this method. In turn this method returns quantity in arbitrary units. Further this method cannot distinguish between host and virus or microbe linked metabolites nor could assess the flux of these metabolites.

Troubleshooting

Problem 1

Leaks in the system (step 20).

Potential solution

Inspect all the fittings for leaks. Tighten any loose fittings, without over tightening them as this may cause damage to the fitting’s threads and cause leaks. Replace the fitting and ferrule if they may be damaged.

Problem 2

No peaks/very small peaks (step 20). First of all, check the lamp is on and cables are well connected. Next make sure if the flow is normal and automatic sampler vials have sufficient liquid and no air bubbles in the sample. If the problem still persists, then evaluate the system performance with fresh standards to confirm if sample is the source of problem.

Problem 3

If the pressure is higher than normal (step 20). Remove the guard and analytical column. Check the pressure, then isolate the cause by systematically eliminating system components, starting with detector, then in-line filter, and working back to pump. Replace filter in pump if present. Replace guard column if necessary. If the analytical column is obstructed, reverse and flush the column while disconnected from the detector. If the problem persists, the column may be clogged with strongly retained contaminants. Therefore, change the column.

Problem 4

If there is a shift in Retention Times (step 20). Check the system for loose fittings. Check pump for leaks, salt buildup, unusual noises. Change pump seals if necessary. Also check make-up of mobile phase and be sure mobile phase is degassed. Purge air from pump head or check valves. Higher column temperatures increase column efficiency. For optimum results, heat eluent before introducing it into the column. Inject smaller volume (e.g., 10 μL vs. 100 μL) or inject the same volume after 1:10 or 1:100 dilutions of sample

Problem 5

If the Resolution is less (step 21). Prepare a fresh mobile phase and check problem 3 for an obstructed guard or analytical column.

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Dr. Jaswinder Singh Maras (jassi2param@gmail.com).

Materials availability

The study did not generate any materials.
REREAGENT or RESOURCESOURCEIDENTIFIER
Chemicals, peptides, and recombinant proteins

Acetonitrile for LCMSJ.T. BakerCat#14650359
Methanol for LCMSSigma-AldrichCat#34860
Pierce™ Positive Ion Calibration SolutionThermo ScientificCat#88323
Pierce™ Negative Ion Calibration SolutionThermo ScientificCat#88324
LC-MS grade Formic acidMerckCAS#64-18-6
Milli-Q water (18 MU)Thermo ScientificCat#W6-4
MetforminSigma-AldrichCAS#1115-70-4
Ethylmalonic acidSigma-AldrichCAS#601-75-2
DihydrostreptomycinSigma-AldrichCAS#5490-27-7
ColchicineSigma-AldrichCAS#64-86-8
ImipramineSigma-AldrichCAS#113-52-0
RoxithromycinSigma-AldrichCAS#80214-83-1
AmilorideSigma-AldrichCAS#2016-88-8
AtropineSigma-AldrichCAS#51-55-8
2-aminoanthraceneSigma-AldrichCAS#613-13-8
PrednisoloneSigma-AldrichCAS#50-24-8
DinosebSigma-AldrichCAS#88-85-7
MCPA 2-methyl-4-chlorophenoxyacetic acidSigma-AldrichCAS#2436-73-9
DimetridazoleSigma-AldrichCAS#551-92-8
AMPA 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl) propanoic acidSigma-AldrichCat#A6816
Viral Transport MediaHimediaCat#MS2760A

Software and algorithms

Compound Discoverer Software 3.1Thermo Fisher ScientificCompound Discoverer™ Software
MetaboAnalyst 4.0Web serverhttps://www.metaboanalyst.ca/

Other

Q Exactive Orbitrap Mass SpectrometerThermo ScientificCat#IQLAAEGAAPFALGMBDK
Hypersil GOLD™ C18 Selectivity HPLC ColumnsThermo ScientificCat#25003102130
200μL pipette tips, Sterile gradeEppendorf® Combitips advancedZ762997
9mm Target DP 300μL HPLC Vial (Polypropylene)Thermo ScientificC4000-11
9mm Autosampler Vial Screw Thread Caps (Blue), PTFE/White Silicone SeptumThermo ScientificC5000-54B
Benchtop centrifugeEppendorfCat#5409000012
SonicatorHelix BiosciencesI.T NO.#HBSNII-92
VortexSigma-AldrichZ258423
Vacuum evaporatorGenevacCat#75871-454

Internal standards for untargeted analysis

ReagentConcentrationAmount
Dinoseb5 μg/mL25 μg
MCPA 2-methyl-4-chlorophenoxyacetic acid5 μg/mL25 μg
Dimetridazole5 μg/mL25 μg
AMPA 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl) propanoic acid5 μg/mL25 μg
Milli-Q watern/aMake-up volume
Total5 mL

External standard for untargeted analysis

ReagentConcentrationAmount
Dihydrostreptomycin20 μg/mL100 μg
Colchicine0.5 μg/mL2.5 μg
Imipramine0.5 μg/mL2.5 μg
Roxithromycin20 μg/mL100 μg
Amiloride10 μg/mL50 μg
Atropine1 μg/mL5 μg
2-aminoanthracene1 μg/mL5 μg
Prednisolone1 μg/mL5 μg
Metformin1 μg/mL5 μg
Ethylmalonic acid3 μg/mL15 μg
Milli-Q waterMake-up volume
Total5 mL

Solvent A for untargeted analysis

ReagentConcentrationAmount (500 mL)
Formic Acid0.1%1 mL
Milli-Q water499 mL

Solvent B for untargeted analysis

ReagentConcentrationAmount (500 mL)
Acetonitrile for LC-MS100%500 mL
Sample – solvent ratioSample%Solvent%
1:1100% sample
1:250% sample50% solvent
1:425% sample75% solvent
1:812.5% sample87.5% solvent
  8 in total

1.  Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry.

Authors:  Samia Boudah; Marie-Françoise Olivier; Sandrine Aros-Calt; Lydie Oliveira; François Fenaille; Jean-Claude Tabet; Christophe Junot
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-04-21       Impact factor: 3.205

2.  Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy.

Authors:  Nicolas Weiss; Pierre Barbier Saint Hilaire; Benoit Colsch; Foucauld Isnard; Suleiman Attala; Augustin Schaefer; Maria Del Mar Amador; Marika Rudler; Foudil Lamari; Frédéric Sedel; Dominique Thabut; Christophe Junot
Journal:  J Hepatol       Date:  2016-08-09       Impact factor: 25.083

3.  Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis.

Authors:  Jasmine Chong; David S Wishart; Jianguo Xia
Journal:  Curr Protoc Bioinformatics       Date:  2019-12

4.  Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.

Authors:  Richard Moreau; Joan Clària; Ferran Aguilar; François Fenaille; Juan José Lozano; Christophe Junot; Benoit Colsch; Paolo Caraceni; Jonel Trebicka; Marco Pavesi; Carlo Alessandria; Frederik Nevens; Faouzi Saliba; Tania M Welzel; Agustin Albillos; Thierry Gustot; Javier Fernández; Christophe Moreno; Maurizio Baldassarre; Giacomo Zaccherini; Salvatore Piano; Sara Montagnese; Victor Vargas; Joan Genescà; Elsa Solà; William Bernal; Noémie Butin; Thaïs Hautbergue; Sophie Cholet; Florence Castelli; Christian Jansen; Christian Steib; Daniela Campion; Raj Mookerjee; Miguel Rodríguez-Gandía; German Soriano; François Durand; Daniel Benten; Rafael Bañares; Rudolf E Stauber; Henning Gronbaek; Minneke J Coenraad; Pere Ginès; Alexander Gerbes; Rajiv Jalan; Mauro Bernardi; Vicente Arroyo; Paolo Angeli
Journal:  J Hepatol       Date:  2019-11-25       Impact factor: 30.083

5.  Baseline urine metabolic phenotype in patients with severe alcoholic hepatitis and its association with outcome.

Authors:  Jaswinder Singh Maras; Sukanta Das; Shvetank Sharma; Saggere M Shasthry; Benoit Colsch; Christophe Junot; Richard Moreau; Shiv Kumar Sarin
Journal:  Hepatol Commun       Date:  2018-04-16

6.  Heat inactivation of the severe acute respiratory syndrome coronavirus 2.

Authors:  Christophe Batéjat; Quentin Grassin; Jean-Claude Manuguerra; India Leclercq
Journal:  J Biosaf Biosecur       Date:  2021-01-23

Review 7.  Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests.

Authors:  Florence Anne Castelli; Giulio Rosati; Christian Moguet; Celia Fuentes; Jose Marrugo-Ramírez; Thibaud Lefebvre; Hervé Volland; Arben Merkoçi; Stéphanie Simon; François Fenaille; Christophe Junot
Journal:  Anal Bioanal Chem       Date:  2021-08-25       Impact factor: 4.142

8.  Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome.

Authors:  Jaswinder Singh Maras; Shvetank Sharma; Adil Bhat; Sheetalnath Rooge; Reshu Aggrawal; Ekta Gupta; Shiv K Sarin
Journal:  iScience       Date:  2021-07-09
  8 in total
  1 in total

1.  Targeting ACLY efficiently inhibits SARS-CoV-2 replication.

Authors:  Terrence Tsz-Tai Yuen; Jasper Fuk-Woo Chan; Bingpeng Yan; Cynthia Cheuk-Ying Shum; Yuanchen Liu; Huiping Shuai; Yuxin Hou; Xiner Huang; Bingjie Hu; Yue Chai; Chaemin Yoon; Tianrenzheng Zhu; Huan Liu; Jialu Shi; Jinjin Zhang; Jian-Piao Cai; Anna Jinxia Zhang; Jie Zhou; Feifei Yin; Shuofeng Yuan; Bao-Zhong Zhang; Hin Chu
Journal:  Int J Biol Sci       Date:  2022-07-11       Impact factor: 10.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.